These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22891356)

  • 1. Advanced solid tumors treated with cediranib: comparison of dynamic contrast-enhanced MR imaging and CT as markers of vascular activity.
    Messiou C; Orton M; Ang JE; Collins DJ; Morgan VA; Mears D; Castellano I; Papadatos-Pastos D; Brunetto A; Tunariu N; Mann H; Tessier J; Young H; Ghiorghiu D; Marley S; Kaye SB; deBono JS; Leach MO; deSouza NM
    Radiology; 2012 Nov; 265(2):426-36. PubMed ID: 22891356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of repeatability and treatment response in early phase clinical trials using DCE-MRI: comparison of parametric analysis using MR- and CT-derived arterial input functions.
    Rata M; Collins DJ; Darcy J; Messiou C; Tunariu N; Desouza N; Young H; Leach MO; Orton MR
    Eur Radiol; 2016 Jul; 26(7):1991-8. PubMed ID: 26385804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neoadjuvant chemotherapy in breast cancer: prediction of pathologic response with PET/CT and dynamic contrast-enhanced MR imaging--prospective assessment.
    Tateishi U; Miyake M; Nagaoka T; Terauchi T; Kubota K; Kinoshita T; Daisaki H; Macapinlac HA
    Radiology; 2012 Apr; 263(1):53-63. PubMed ID: 22438441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic cancer: utility of dynamic contrast-enhanced MR imaging in assessment of antiangiogenic therapy.
    Akisik MF; Sandrasegaran K; Bu G; Lin C; Hutchins GD; Chiorean EG
    Radiology; 2010 Aug; 256(2):441-9. PubMed ID: 20515976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tracer kinetics analysis of dynamic contrast-enhanced CT and MR data in patients with squamous cell carcinoma of the upper aerodigestive tract: comparison of the results.
    Bisdas S; Baghi M; Wagenblast J; Bisdas T; Thng CH; Mack MG; Koh TS; Ernemann U
    Clin Physiol Funct Imaging; 2009 Sep; 29(5):339-46. PubMed ID: 19473200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of neuroendocrine liver metastases: a comparison of dynamic contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography.
    Armbruster M; Sourbron S; Haug A; Zech CJ; Ingrisch M; Auernhammer CJ; Nikolaou K; Paprottka PM; Rist C; Reiser MF; Sommer WH
    Invest Radiol; 2014 Jan; 49(1):7-14. PubMed ID: 24002080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic contrast-enhanced magnetic resonance imaging as a pharmacodynamic measure of response after acute dosing of AG-013736, an oral angiogenesis inhibitor, in patients with advanced solid tumors: results from a phase I study.
    Liu G; Rugo HS; Wilding G; McShane TM; Evelhoch JL; Ng C; Jackson E; Kelcz F; Yeh BM; Lee FT; Charnsangavej C; Park JW; Ashton EA; Steinfeldt HM; Pithavala YK; Reich SD; Herbst RS
    J Clin Oncol; 2005 Aug; 23(24):5464-73. PubMed ID: 16027440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
    Mendichovszky IA; Cutajar M; Gordon I
    Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic Contrast-enhanced MR Imaging of Advanced Hepatocellular Carcinoma: Comparison with the Liver Parenchyma and Correlation with the Survival of Patients Receiving Systemic Therapy.
    Chen BB; Hsu CY; Yu CW; Liang PC; Hsu C; Hsu CH; Cheng AL; Shih TT
    Radiology; 2016 Nov; 281(2):454-464. PubMed ID: 27171020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of the reproducibility of free-breathing diffusion-weighted MRI and dynamic contrast enhanced MRI in children with solid tumours: a pilot study.
    Miyazaki K; Jerome NP; Collins DJ; Orton MR; d'Arcy JA; Wallace T; Moreno L; Pearson AD; Marshall LV; Carceller F; Leach MO; Zacharoulis S; Koh DM
    Eur Radiol; 2015 Sep; 25(9):2641-50. PubMed ID: 25773937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic contrast-enhanced computed tomography imaging biomarkers correlated with immunohistochemistry for monitoring the effects of sorafenib on experimental prostate carcinomas.
    Cyran CC; von Einem JC; Paprottka PM; Schwarz B; Ingrisch M; Dietrich O; Hinkel R; Bruns CJ; Clevert DA; Eschbach R; Reiser MF; Wintersperger BJ; Nikolaou K
    Invest Radiol; 2012 Jan; 47(1):49-57. PubMed ID: 21934514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of quantitative parameters in cervix cancer measured by dynamic contrast-enhanced MRI and CT.
    Yang C; Stadler WM; Karczmar GS; Milosevic M; Yeung I; Haider MA
    Magn Reson Med; 2010 Jun; 63(6):1601-9. PubMed ID: 20512864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
    Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
    Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voxelwise comparison of perfusion parameters estimated using dynamic contrast enhanced (DCE) computed tomography and DCE-magnetic resonance imaging in locally advanced cervical cancer.
    Kallehauge J; Nielsen T; Haack S; Peters DA; Mohamed S; Fokdal L; Lindegaard JC; Hansen DC; Rasmussen F; Tanderup K; Pedersen EM
    Acta Oncol; 2013 Oct; 52(7):1360-8. PubMed ID: 24003852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumoral and nontumoral pancreas: correlation between quantitative dynamic contrast-enhanced MR imaging and histopathologic parameters.
    Bali MA; Metens T; Denolin V; Delhaye M; Demetter P; Closset J; Matos C
    Radiology; 2011 Nov; 261(2):456-66. PubMed ID: 21852570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early antiangiogenic activity of SU11248 evaluated in vivo by dynamic contrast-enhanced magnetic resonance imaging in an experimental model of colon carcinoma.
    Marzola P; Degrassi A; Calderan L; Farace P; Nicolato E; Crescimanno C; Sandri M; Giusti A; Pesenti E; Terron A; Sbarbati A; Osculati F
    Clin Cancer Res; 2005 Aug; 11(16):5827-32. PubMed ID: 16115922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SHILO, a novel dual imaging approach for simultaneous HI-/LOw temporal (Low-/Hi-spatial) resolution imaging for vascular dynamic contrast enhanced cardiovascular magnetic resonance: numerical simulations and feasibility in the carotid arteries.
    Calcagno C; Robson PM; Ramachandran S; Mani V; Kotys-Traughber M; Cham M; Fischer SE; Fayad ZA
    J Cardiovasc Magn Reson; 2013 May; 15(1):42. PubMed ID: 23706156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamic contrast-enhanced MRI in head-and-neck cancer: the impact of region of interest selection on the intra- and interpatient variability of pharmacokinetic parameters.
    Craciunescu OI; Yoo DS; Cleland E; Muradyan N; Carroll MD; MacFall JR; Barboriak DP; Brizel DM
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):e345-50. PubMed ID: 21985945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic contrast-enhanced micro-CT on mice with mammary carcinoma for the assessment of antiangiogenic therapy response.
    Eisa F; Brauweiler R; Hupfer M; Nowak T; Lotz L; Hoffmann I; Wachter D; Dittrich R; Beckmann MW; Jost G; Pietsch H; Kalender WA
    Eur Radiol; 2012 Apr; 22(4):900-7. PubMed ID: 22071777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reproducibility and comparison of DCE-MRI and DCE-CT perfusion parameters in a rat tumor model.
    Ng CS; Waterton JC; Kundra V; Brammer D; Ravoori M; Han L; Wei W; Klumpp S; Johnson VE; Jackson EF
    Technol Cancer Res Treat; 2012 Jun; 11(3):279-88. PubMed ID: 22417064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.